LYON, France , May 6, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported the first Focal One HIFU treatments performed in Germany . The Department of Urology at the Fuerth Hospital , Germany , headed by Dr.
Farrer Park Hospital becomes the first hospital in Southeast Asia to implement Focal One ® EDAP poised to expand HIFU in Southeast Asia LYON, France , November 26, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, announced today that the first Focal
Ablatherm Robotic HIFU Deployed by HIFU USA; Initial Treatments Performed in New York by Dr. Ron Israeli and in New England by Drs. Clifford Gluck and James Lin
· First patients already treated as recruitment accelerates LYON, France , September 3, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first two patients have been treated in the company’s Phase 2 clinical trial assessing
EDAP Announces First Published Long-Term Study of HIFU for Localized Prostate Cancer LYON, France, Dec. 13, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces the release of the first multi-center
- Record first quarter revenue - - Positive results from two studies reconfirm safety and efficacy of Focal One - - Company to host conference call and webcast today, Wednesday, May 17 th at 8:30 am EDT - LYON, France, May 17, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic
World's Largest Prostate Cancer Clinic at University Hospital Hamburg-Eppendorf Expands Range of Treatment Options to Include Next-Generation Focal Therapy
Final rule significantly raises Medicare reimbursement to U.S. hospital s performing a Focal One HIFU prostate ablation procedure LYON, France, November 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic therapeutic ultrasound, today announced that the U.S.
Proposed rule, if adopted for CY23 , would increase Medicare Payment for a Focal One HIFU procedure completed on an outpatient basis at a hospital LYON, France, July 18, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the
